
ResMed Corp. To Pay $37.5 Million In FCA Settlement
Blog Post Authors: John Roberts (jroberts@sfmslaw.com); Nicolas A. Lussier (nlussier@sfmslaw.com) On January 15, 2020, medical equipment manufacturer ResMed Corp. (“ResMed”) agreed to pay $37.5 million to settle claims brought against it in five qui tam lawsuits under the False Claims Act (“FCA”) and Anti-Kickback Statute (“AKS”). The underlying lawsuits alleged that ResMed was providing illegal […]